Charts

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion ...

Goldman Sachscompiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A ...

Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 23 newly-hired, non-executive employees.

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in IVERIC bio Inc (ISEE), where a total volume of 21,134 contracts has been traded thus far today, a contract volume which is representative of approximately 2.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50.2% of ISEE's average daily trading volume over the past month, of 4.2 million shares..

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IVERIC bio, Inc. (NasdaqGS: ISEE) to Astellas Pharma Inc. Under the terms of the proposed transaction, shareholders of IVERIC will receive $40.00 in cash for each share of IVERIC that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Castle Biosciences Inc (CSTL), where a total volume of 2,142 contracts has been traded thus far today, a contract volume which is representative of approximately 214,200 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 95.5% of CSTL's average daily trading volume over the past month, of 224,370 shares..

Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock.

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track ...

Upgrades According to OTR Global, the prior rating for Ritchie Bros Auctioneers Inc (NYSE:RBA) was changed from Mixed to Positive. For ...

Upgrades For The Trade Desk Inc (NASDAQ:TTD), Vertical Research upgraded the previous rating of Neutral to Positive. Trade Desk earned ...

Upgrades According to Colliers Securities, the prior rating for Centerspace (NYSE:CSR) was changed from Neutral to Buy. In the first ...

These three biotech stocks were on the volatile side today.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zynex Inc (ZYXI), where a total of 8,607 contracts have traded so far, representing approximately 860,700 underlying shares. That amounts to about 570.5% of ZYXI's average daily trading volume over the past month of 150,875 shares..

Upgrades Telsey Advisory Group upgraded the previous rating for Allbirds Inc (NASDAQ:BIRD) from Market Perform to Outperform. Allbirds ...

Astellas Pharma snapped up Iveric Bio for $5.9 billion in cash, the companies said Monday in an announcement that sent ISEE stock flying.

Benzinga First Republic Folds As Banking Crisis Claims Third Victim: JPMorgan To Buy Deposits, Assets TheFirst Republic ...

Gainers Apollomics (NASDAQ:APLM) stock increased by 40.1% to $6.5 during Monday's pre-market session. The market value of their ...

Stocks have reverted to their cautious ways on Monday amid a slew of market-moving catalysts. The Federal Deposit Insurance Corporation ...

Japanese healthcare companyAstellas Pharma Inc(OTC: ALPMY) has agreed to buyIveric Bio Inc(NASDAQ: ISEE) for ...

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading ...

Onto our call of the day from the team at Evercore ISI, where senior managing director Julian Emanuel say investors should get ready for a Fed pause after one last 25 basis point hike this week.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Iveric bio, Inc. (NASDAQ: ISEE) to Astellas Pharma Inc. for $40.00 per share in cash is fair to Iveric shareholders.

The Japanese company said it would pay $40.00 per share of Iveric, which booked net loss of $185.2 million and had $534.7 million in net assets in 2022.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and IVERIC Bio, Inc. (NASDAQ: ISEE, CEO: Glenn P. Sblendorio, “Iveric Bio”) today announced that on April 29, 2023 (Japan time), the Companies have entered into a definitive agreement under which Astellas through Berry Merger Sub, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc., has agreed to acquire 100% of the outstanding shares of Iveric Bio for US$40.00 per share in cash for a total equity value of approximately US$5.9 billion (the “Acquisition”). In the Acquisition, Iveric Bio will become an indirectly wholly-owned subsidiary of Astellas. The total equity value of Iveric Bio in the Acquisition assumes that there are approximately 148.2 million outstanding shares of Iveric Bio common stock on a fully diluted basis. The purchase price represents a premium of 64% to Iveric Bio’s unaffected closing share price of US$24.33 on March 31, 2023, and a premium of 75% to Iveric Bio’s 30 trading day volume weighted average price as of March 31, 2023. The Boards of Directors of both companies have unanimously approved the transaction.

Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings: Bullish Somewhat ...

In recent trading, shares of IVERIC bio Inc (ISEE) have crossed above the average analyst 12-month target price of $29.64, changing hands for $29.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..

Iveric Bio announced new findings from exploratory analyses of data for ACP, presented at the 2023 annual meeting of the ARVO in New Orleans.

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in IVERIC bio Inc (ISEE), where a total volume of 14,177 contracts has been traded thus far today, a contract volume which is representative of approximately 1.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 73.2% of ISEE's average daily trading volume over the past month, of 1.9 million shares..

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Academy Sports & Outdoors Inc (ASO), where a total of 13,012 contracts have traded so far, representing approximately 1.3 million underlying shares. That amounts to about 74.8% of ASO's average daily trading volume over the past month of 1.7 million shares..

Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to ...

Symbols mentioned in this story: XBI, VKTX, SGEN, ISEE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand..

Over the past 3 months, 4 analysts have published their opinion on IVERIC bio (NASDAQ:ISEE) stock. These analysts are typically employed ...

Gainers Hitek Global Inc. (NASDAQ: HKIT) jumped 25.5% to $6.98 in pre-market trading after gaining 11% on Friday. Hitek Global ...

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading ...

ISEE earnings call for the period ending December 31, 2022.

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of ...

IVERIC bio Inc(NASDAQ: ISEE)announced an exploratorytime-to-event analysis from the avacincaptad pegol (ACP) GATHER ...

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in ...

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue ...

Iveric Bio announced financial and operating results for the fourth quarter and full year ended Dec. 31, 2022 and provided a general business update.

Iveric Bio announced an analysis from the ACP GATHER clinical trial program evaluating reduction in vision loss with ACP 2 mg versus sham treatment.